SHOCKWAVE MED INC's ticker is SWAV and the CUSIP is 82489T104. A total of 222 filers reported holding SHOCKWAVE MED INC in Q4 2020. The put-call ratio across all filers is 0.31 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,302,551 | -30.2% | 21,610 | 0.0% | 0.02% | -23.8% |
| Q2 2023 | $6,167,710 | +31.6% | 21,610 | 0.0% | 0.02% | +23.5% |
| Q1 2023 | $4,685,696 | +5.5% | 21,610 | 0.0% | 0.02% | 0.0% |
| Q4 2022 | $4,443,232 | -26.1% | 21,610 | 0.0% | 0.02% | -29.2% |
| Q3 2022 | $6,009,000 | +45.5% | 21,610 | 0.0% | 0.02% | +50.0% |
| Q2 2022 | $4,131,000 | +0.4% | 21,610 | +9.0% | 0.02% | +23.1% |
| Q1 2022 | $4,113,000 | +16.3% | 19,833 | 0.0% | 0.01% | +30.0% |
| Q4 2021 | $3,537,000 | -14.4% | 19,833 | -1.2% | 0.01% | -23.1% |
| Q3 2021 | $4,134,000 | +7.2% | 20,082 | -1.2% | 0.01% | 0.0% |
| Q2 2021 | $3,856,000 | +60.5% | 20,321 | +10.1% | 0.01% | +62.5% |
| Q1 2021 | $2,403,000 | -16.2% | 18,450 | -33.3% | 0.01% | -20.0% |
| Q4 2020 | $2,867,000 | +1.6% | 27,643 | -25.7% | 0.01% | -9.1% |
| Q3 2020 | $2,821,000 | – | 37,217 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prossimo Advisors, LLC | 18,758 | $3,735 | 8.81% |
| Matisse Capital | 22,175 | $4,415,043 | 3.12% |
| Atika Capital Management LLC | 116,500 | $23,195,150 | 3.04% |
| APEIRON CAPITAL Ltd | 18,300 | $3,643,530 | 2.44% |
| AtonRa Partners | 4,374 | $870,863 | 1.83% |
| Rhenman & Partners Asset Management AB | 81,000 | $16,127,100 | 1.74% |
| GILDER GAGNON HOWE & CO LLC | 549,173 | $109,340,363 | 1.66% |
| Eversept Partners, LP | 84,462 | $16,816,384 | 1.42% |
| Biondo Investment Advisors, LLC | 37,451 | $7,456,394 | 1.40% |
| DEEPWATER ASSET MANAGEMENT, LLC | 15,321 | $3,050,411 | 1.40% |